metricas
covid
Buscar en
Revista Española de Cirugía Ortopédica y Traumatología (English Edition)
Toda la web
Inicio Revista Española de Cirugía Ortopédica y Traumatología (English Edition) Use of adipose-derived stem cells in an experimental rotator cuff fracture anima...
Journal Information
Vol. 59. Issue 1.
Pages 3-8 (January - February 2015)
Visits
1260
Vol. 59. Issue 1.
Pages 3-8 (January - February 2015)
Research
Full text access
Use of adipose-derived stem cells in an experimental rotator cuff fracture animal model
Uso de células troncales derivadas de lipoaspirado en un modelo experimental animal de rotura de manguito rotador
Visits
1260
R. Barcoa,
Corresponding author
raulbarco@hotmail.com

Corresponding author.
, C. Encinasa, M. Valenciaa, M.T. Carrascalb, M. García-Arranzc, S. Antuñaa
a Servicio de Cirugía Ortopédica y Traumatología, IDIPAZ, Madrid, Spain
b Departamento de Medicina. Escuela Técnica Superior Ingeniaría Industrial, UNED, Madrid, Spain
c Unidad de Terapia Celular, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Madrid, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (2)
Table 1. Biomechanical results of the repair of the supraspinatus tendon after 4 weeks.
Table 2. Biomechanical results of the repair of the supraspinatus tendon after 8 weeks.
Show moreShow less
Abstract
Aim

Rotator cuff repairs have shown a high level of re-ruptures. We hypothesized that the use of adipose-derived stem cells (ASC) could improve the biomechanical and histological properties of the repair.

Materials and methods

Controlled experimental study conducted on 44 BDIX rats with section and repair of the supraspinatus tendon and randomization to one of three groups: group A, no intervention (control); group B, local applications of a fibrin sealant; and group C, application of the fibrin sealant with 2×106 ASC. At 4 and 8 weeks a biomechanical and histological analysis was performed.

Results

There were no differences in load-to-failure at 4 and 8 weeks between groups. The load-to-failure did increase between week 4 and week 8. Histologically the tendon-to bone union showed a disorganized fibrovascular tissue. Group C showed a different inflammatory pattern, with less presence of neutrophils and more presence of plasma cells.

Conclusion

The use of ASC does not improve the biomechanical or histological properties of the repair site. More studies are needed to improve techniques that enhance the healing site of the repair.

Keywords:
Cell therapy
Repair
Supraspinatus
Experimental
Adipose-derived stem-cell
Resumen
Objetivo

La reparación del manguito rotador tiene una alta tasa de fracaso. Se investiga si la aplicación de células troncales derivadas de lipoaspirado mejorará la resistencia de la reparación y recreará la entesis original.

Material y métodos

Estudio experimental en 44 ratas BDIX con sección y reparación con sutura del tendón supraespinoso y asignación aleatoria a uno de 3 grupos: grupo A, nada (control); grupo B, aplicación local de vehículo de fibrina; y grupo C, aplicación de 2×106 células troncales derivadas de lipoaspirado. Se realiza estudio mecánico en célula de carga y estudio histológico en hematoxilina-eosina.

Resultados

En el estudio mecánico no hubo diferencias entre grupos. La carga hasta el fracaso aumentó de los grupos de 4–8 semanas. En el estudio histológico se observó la unión hueso-tendón mediante un tejido fibrovascular desorganizado. En el grupo C se observó un aumento de células plasmáticas a las 4 y 8 semanas.

Conclusión

La utilización de células troncales derivadas de lipoaspirado no recrea la organización celular de la entesis ni mejoran las propiedades biomecánicas de la misma. Son necesarios más estudios para investigar técnicas que mejoren la cicatrización del tendón.

Palabras clave:
Terapia celular
Reparación
Manguito rotador
Experimental
Celula troncal derivada de lipoaspirado
Full Text
Introduction

The existence of re-ruptures after rotator cuff repairs is still a frequent problem, with some studies reporting an incidence of up to 94% in massive tears.1,2 In addition, the functional results of patients with complete repairs are better than those obtained in cases where the repair failed.3

The majority of tears present degenerative changes in the local biology of the tendons which include, among others, an increase in cellular apoptosis and alterations in the levels of matrix metalloproteases and various growth factors. Repair of the rotator cuff does not manage to recreate the native structure of the enthesis or its original biomechanical strength.4,5

The 2 factors affecting healing of the enthesis include the mechanical resistance of the repair and the biological environment, which affects scarring. There has been considerable work focused on increasing the mechanical resistance of repairs, however, there is less information regarding modification of the local biological environment through the use of therapies to improve scarring.6 The use of mesenchymal stem cells has been one of the strategies explored to biologically improve these repairs.7 Stem cells are fibroblastic cells which are able to differentiate toward various different cellular types, including osteoblasts and chondrocytes. Their 2 main sources are the bone marrow and adipose tissue, which is more accessible and has greater proliferative power.8

Our hypothesis is that the local application of adipose-derived stem cells (ASC) in a rotator cuff animal model would improve the mechanical resistance of repairs, as well as the histological structure of the enthesis.

Materials and methods

In order to study tendon-to-bone unions in a rotator cuff model we used a total of 24 syngeneic BDIX rats aged between 6 and 8 weeks in the biomechanical study and 18 animals for the histological study. The work was approved by the Ethics Committee for animal experimentation at our center and we followed all the international guidelines for experimentation with animals (86/609/CEE).

Collection of adipose-derived stem cells (Appendix A)

The method to obtain ASC has been published previously.9 In short, the cells were extracted from the epiploon and subcutaneous fat of 2 animals and were then submitted to mechanical disaggregation and enzymatic cellular digestion. Next, the cellular phase was selected and the ASC were isolated. We verified the cell lineage through differentiation of the cells into adipocytes, chondrocytes and osteocytes, as well as by flow cytometry studies of membrane markers (positive CD 90, CD 73 and CD 105 and negative CD 34, CD 44). Lastly, we multiplied the cells in an adequate medium and carried out a cell count before application.

Surgical technique

The surgical technique has been described previously.10 In short, a longitudinal incision was made on the proximal part of the front leg with horizontal section of the deltoid, exposing the rotator cuff of the animal. Next, the tendon of the trochiter supraspinatus was sectioned and the animals were randomly divided into 3 groups using an electronic method (Excel, Microsoft, Redmond, VA, USA). The first group underwent repair of the supraspinatus tendon to the trochiter through an anteroposterior bone tunnel using 5/0 monofilament non-resorbable suture. The second group underwent the same repair with a fibrin sealant applied on the repair area (Tissucol, Baxter, Deerfield, IL, USA). The third group underwent tendon repair and application of 2×106 ASC imbibed in fibrin sealant. After assigning each subject to an experimental group, we closed the deltoid with reabsorbable suture and the skin with 3/0 silk suture.

Histological and biomechanical study (Appendix B)

The animals were sacrificed after 4 or 8 weeks from the repair. The specimens were prepared for the biomechanical study by individualizing the scapula, the myotendinous unit of the supraspinatus and the humerus, and introduced in a 2ml syringe with a polymethylmethacrylate (PMMA) bone cement medium (CMW-1, De-Puy, Johnson & Johnson, Warsaw, IN, USA) in order to include them in a lineal electrohydraulic load cell (ControlTest, Servosis, Madrid, Spain). The specimens were preloaded at 0.1N and tested until failure at a speed of 14μm/s. The maximum load until failure and the location of the failure were recorded. The rigidity of the sample was calculated by determining the lineal part of the ascending slope of the load-displacement curve.7

For the histological study we individualized the scapula and upper limb up to the elbow and fixed them in a 10% formalin solution with a decalcifying solution (EDTA) and imbibed them in paraffin in order to obtain histological sections. The sections were 5μm in the coronal plane and stained with hematoxylin and eosin. The histological study was carried out by a pathologist who was unaware of the experimental group to which each sample belonged. The study was conducted in 2 different periods, in order to make it more homogeneous. A third reading of the study was obtained when discrepancies arose. We paid special attention to the trochiter, insertion of the tendon-bone repair and supraspinatus tendon per se, using an optical microscope. We carried out a study of the microscopic histological qualities, like inflammatory infiltrate, vascularization and cellular and fibrillary organization of the enthesis.

Results

Two animals died due to anesthetic complications and were replaced so as to maintain the predetermined experimental figure. All the animals had achieved normal mobility by 7 days after the intervention. There were no other postoperative complications.

The biomechanical study showed no significant differences between any of the groups for any of the studied variables. The mean load until failure was 12.83N for group 1, 11.57N for group 2 and 11.72N for group 3 after 4 weeks (P=.67) (Table 1). In the animals analyzed after 8 weeks, the mean load until failure was 15.11N in group 1, 15.94N in group 2 and 14.35N in group 3 (P=.88) (Table 2).

Table 1.

Biomechanical results of the repair of the supraspinatus tendon after 4 weeks.

Group  Load until failure (N)  Maximum deformation (mm)  Rigidity (N/mm2Energy absorbed (J) 
Control  12.83±3.79  3.99±2.11  5.27±3.11  0.069±0.035 
Fibrin sealant  11.57±2.08  4.21±1.72  3.50±1.68  0.051±0.019 
ASC  11.72±3.98  5.13±1.78  2.93±1.07  0.080±0.080 
P  .67  .41  .11  .47 

ASC: adipose-derived stem cells.

Table 2.

Biomechanical results of the repair of the supraspinatus tendon after 8 weeks.

Group  Load until failure (N)  Maximum deformation (mm)  Rigidity (N/mm2Energy absorbed (J) 
Control  15.11±5.75  8.32±4.83  4.10±1.90  0.120±0.051 
Fibrin sealant  15.94±5.50  5.09±3.10  4.30±1.94  0.079±0.067 
ASC  14.35±4.16  6.46±1.69  3.53±1.61  0.096±0.37 
P  .88  .23  .79  .33 

ASC: adipose-derived stem cells.

The necropsy test did not reveal any significant differences between the study groups, although the tissue was found to be more robust in the groups sacrificed after 8 weeks than in those sacrificed after 4 weeks.

The histological study found an immature enthesis in the groups sacrificed after 4 weeks evolution, with a more disorganized and highly cellular structure, and an abundance of inflammatory cells, compared to the groups sacrificed after 8 weeks, which presented a slightly more organized structure, with a better alignment of the collagen fibers and with no differences between groups (Fig. 1). The samples analyzed with mesenchymal cells only presented a lower inflammatory response after 4 weeks, although we did not carry out any additional studies to quantify the difference, which disappeared in the groups sacrificed after 8 weeks (Fig. 2). We observed the presence of cells marked with green fluorescent protein after 4 weeks.

Figure 1.

Histological section (hematoxylin–eosin, ×40) of the enthesis after 4 weeks evolution. The enthesis appears highly cellular and notably disorganized.

(0.18MB).
Figure 2.

Histological section (hematoxylin–eosin, ×40) of the enthesis after 8 weeks evolution. The fibrillary structure of the enthesis shows a more organized arrangement, although its orientation is still not parallel to the native enthesis.

(0.17MB).
Discussion

The high rate of failures following surgical repair has raised the existence of an intrinsic biological problem with the tendon. The enthesis is not regenerated by the surgical repair but instead is substituted by scar tissue which has less mechanical resistance than native tissue and may predispose it to suffer new ruptures.5 The objective of biological therapies is to improve the biological environment around the repair in order to restore the microscopic structure of the native insertion. Growth factors and extracellular matrices have been used with modest results.11–15 Cellular therapy could play an important role in the treatment of rotator cuff tendon lesions.7,16,17

The present work considered the hypothesis that local application of adipose-derived stem cells would improve the biomechanical resistance of the repair as a result of an improved cellular organization. However, the results of the study have not supported this hypothesis.

Mesenchymal stem cells from bone marrow have improved scarring of the tendon to the bone in some previous experimental models of knee cruciate ligament and flexor hallucis longus in rabbits.16,17 The use of isolated stem cells derived from bone marrow did not improve the histology or biomechanical properties of rotator cuff repair in rats. Possible causes considered included the existence of a small contact area between the tendon and the bone, nonexistence of postoperative immobilization and the possibility of insufficient molecular signaling necessary to achieve scarring in such a complex area, which would point to the biological complexity of the repair in these lesions. The use of various biological therapies in combination seems to improve the biomechanical and histological results.7,18,19

ASC are easily obtained, genetically stable, with a nearly unlimited proliferative potential and immunoprivileged, as they lack the HLA-DR haplotype. Guilak et al. proved that these cells are able to reduce inflammation, differentiate and induce revascularization.20 In studies on humans, they have been shown to be safe and effective in the treatment of perianal and tracheoesophageal fistulas.21,22 We did not register any complications derived from the use of stem cells and confirmed the experience of other authors.23,24 Assuming equal results as those obtained with stem cells derived from the bone marrow, these advantages would make them attractive for use in rotator cuff repairs.

In our experimental model, ASC did not improve the mechanical resistance or histological appearance of the repair. Despite the fact that some authors suggested a possible influence of mesenchymal cells after 8 weeks of evolution, we were not able to demonstrate any differences.7 Moreover, we did not find any significant differences after 4 weeks. Perhaps an analysis after 2 weeks would have shown differences that we were not able to detect. The number of cells used was equal to that in other previously used and validated models, but it is possible that this amount was insufficient or that the site of the repair lacked the molecular signals necessary to induce differentiation of the cells we applied.7,13,16 Other authors have pointed to the difficulty in establishing the correct dose and adequate sealant to achieve true tendon regeneration rather than scarring of the enthesis.25 It is possible that dispersion of the cells in a fibrin sealant was not capable of containing the cells locally or that the dose used was insufficient or else that the complexity of the necessary molecular signals for the repair without scar cannot be reproduced by the isolated addition of cells.

Further studies focused on combining various inducers of cellular differentiation are required to increase our current knowledge about the specifics of scarring of the rotator cuff.

Level of evidence

Level of evidence I.

Ethical responsibilitiesProtection of people and animals

The authors declare that this investigation adhered to the ethical guidelines of the Committee on Responsible Human Experimentation, as well as the World Medical Association and the Declaration of Helsinki.

Confidentiality of data

The authors declare that this work does not reflect any patient data.

Right to privacy and informed consent

The authors declare that this work does not reflect any patient data.

Financing

This project was financed through a grant from the Spanish Society of Orthopedic Surgery and Traumatology (grant number: BE67322009).

Conflict of interests

The authors have no conflict of interests to declare.

Appendix A
Collection and culture of adipose-derived stem cells

The cells were obtained from the adipose tissue of 2 additional rats according to a protocol described in humans with minimal modifications.24 In short, the adipose tissue was washed with saline solution buffered with phosphate (PBS; Gibco, Invitrogen, Paisley, UK) and exposed to collagenase (type I; Gibco, Invitrogen) for 30min at 37°C. Enzyme activity was neutralized by the addition of 10% fetal bovine serum (FBS; Gibco) and the mixture obtained was centrifuged at 300G for 10min. The cellular remnant was treated with 160mM ammonium chlorhydrate for 10min to produce the lysis of any remaining erythrocytes. The cells were washed and suspended in Dulbecco modified Eagle medium (DMEM) and 10% fetal bovine serum. We carried out a third centrifugation and the resulting cellular suspension was filtered through a 70μm nylon mesh. Subsequently, the material obtained was suspended in DMEM with glucose and pyruvate, 10% bovine fetal serum, 1% 2mM glutamine, 10μm/ml streptomycin and 1IU/ml penicillin. The product thus obtained was called vascular stromal fraction (VSF). These cells were cultured in 100mm trays in concentrations of 10–15 cells/ml at a temperature of 37°C in a humid atmosphere with 5% carbon dioxide in DMEM with 10% fetal bovine serum and 1% streptomycin/penicillin (Gibco, BRL). The medium was changed to remove non-adhered cells 24h after incorporation in the tray and subsequently every 4 days. For derived cultures, the cells were disaggregated with 0.05% trypsin (v7 v) in a saline solution buffered with phosphate when a cellular confluence of 70–80% was obtained. We carried out studies of cellular characterization by flow cytometry analyzing the expression of surface markers CD90, CD29, CD45 and CD11b in order to confirm the ASC phenotype of the cultured cells.

We marked the cells with green fluorescent protein (GFP) following the indications of the manufacturer.

Appendix B
Histological analysis

We carried out euthanasia of the animals at the predetermined periods using an intracardiac injection of chlorhydric potassium under general anesthesia and obtained the specimens for the histological study. The specimens consisted of the complete glenohumeral joint, including the deltoid muscle. These were fixed with a 4% formaldehyde solution, decalcified in EDTA for 14–21 days, and imbibed in paraffin. The samples were analyzed using a conventional optical microscope. The samples marked with green fluorescent protein were analyzed with a Leyca DMI 6000 inverted microscope.

B.1
Biomechanical analysis

Sample preparation. Three groups with comparable weights were established preoperatively and at the time of sacrifice. At 4 and 8 weeks, the animals were euthanized with an intracardiac injection of chlorhydric potassium under general anesthesia and the specimens for the biomechanical study were obtained. Each sample was dissected to isolate the scapula, humerus and supraspinatus tendon. The humerus was placed in a 2mL syringe and fixed with polymethylmethacrylate cement. During polymerization of the cement and to avoid damage caused by the exothermic effects of the reaction, the tendon was protected in a saline solution. The specimens were frozen at a temperature of -80°C at the time of the biomechanical analysis and unfrozen at room temperature 12h before the test.

Biomechanical test. The biomechanical test was carried out in a specific electromechanical device consisting of a lineal encoder with a position sensor and 2 load cells of 20N and 200N, calibrated to detect small loads. The data were registered in the software program (PCD-2K) designed specifically for Windows 7. We obtained tension-deformation curves and carried out calculations of maximum load until failure (N), rigidity (N/mm2), absorbed energy (J) and maximum deformation (mm). The scapula was fixed in one of the load cells with a support in order to enable the tendon to be aligned with the appropriate load direction. The specimens were preloaded at 0.10N and then loaded until failure of the tendon at a rate of 14μs−1.

References
[1]
L.M.B.C. Galatz, S.A. Teefey, W.D. Middleton, K. Yamaguchi.
The outcome and repair integrity of completely arthroscopically repaired large and massive rotator cuff tears.
J Bone Joint Surg Am, 86-A (2004), pp. 219-224
[2]
P. Boileau, N. Brassart, D.J. Watkinson, M. Carles, A.M. Hatzidakis, S.G. Krishnan.
Arthroscopic repair of full-thickness tears of the supraspinatus: does the tendon really heal?.
J Bone Joint Surg Am, 87 (2005), pp. 1229-1240
[3]
C. Gerber, B. Fuchs, J. Hodler.
The results of repair of massive tears of the rotator cuff.
J Bone Joint Surg Am, 82 (2000), pp. 505-515
[4]
J.E. Carpenter, S. Thomopoulos, C.L. Flanagan, C.M. DeBano, L.J. Soslowsky.
Rotator cuff defect healing: a biomechanical and histologic analysis in an animal model.
J Shoulder Elbow Surg, 7 (1998), pp. 599-605
[5]
L.M. Galatz, L.J. Sandell, S.Y. Rothermich, R. Das, A. Mastny, N. Havlioglu, et al.
Characteristics of the rat supraspinatus tendon during tendon-to-bone healing after acute injury.
J Orthop Res, 24 (2006), pp. 541-550
[6]
S.A. Rodeo.
Biologic augmentation of rotator cuff tendon repair.
J Shoulder Elbow Surg, 16 (2007), pp. S191-S197
[7]
L.V. Gulotta, D. Kovacevic, J.R. Ehteshami, E. Dagher, J.D. Packer, S.A. Rodeo.
Application of bone marrow-derived mesenchymal stem cells in a rotator cuff repair model.
Am J Sports Med, 37 (2009), pp. 2126-2133
[8]
M.Á. Ruiz-Ibán, J. Díaz-Heredia, I. García-Gómez, F. Gonzalez-Lizán, E. Elías-Martín, V. Abraira.
The effect of the addition of adipose-derived mesenchymal stem cells to a meniscal repair in the avascular zone: an experimental study in rabbits.
Arthroscopy, 27 (2011), pp. 1688-1696
[9]
D. García-Olmo, M. Garcia-Arranz, L.G. García, E.S. Cuellar, I.F. Blanco, L.A. Prianes, et al.
Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy.
Int J Colorectal Dis, 18 (2003),
[10]
S. Thomopoulos, G. Hattersley, V. Rosen, M. Mertens, L. Galatz, G.R. Williams, et al.
The localized expression of extracellular matrix components in healing tendon insertion sites: AN in situ hybridization study.
J Orthop Res, 20 (2002), pp. 454-463
[11]
S. Antuna, R. Barco, J.M. Martinez Diez, J.M. Sanchez Marquez.
Platelet-rich fibrin in arthroscopic repair of massive rotator cuff tears: a prospective randomized pilot clinical trial.
Acta Orthop Belg, 79 (2013), pp. 25-30
[12]
S.A. Rodeo, D. Delos, R.J. Williams, R.S. Adler, A. Pearle, R.F. Warren.
The effect of platelet-rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study.
Am J Sports Med, 40 (2012), pp. 1234-1241
[13]
D. Kovacevic, S.A. Rodeo.
Biological augmentation of rotator cuff tendon repair.
Clin Orthop Relat Res, 466 (2008), pp. 622-633
[14]
J.P. Iannotti, M.J. Codsi, Y.W. Kwon, K. Derwin, J. Ciccone, J.J. Brems.
Porcine small intestine submucosa augmentation of surgical repair of chronic two-tendon rotator cuff tears. A randomized, controlled trial.
J Bone Joint Surg Am, 88 (2006), pp. 1238-1244
[15]
A. Aurora, J. McCarron, J.P. Iannotti, K. Derwin.
Commercially available extracellular matrix materials for rotator cuff repairs: state of the art and future trends.
J Shoulder Elbow Surg, 16 (2007), pp. S171-S178
[16]
J.K. Lim, J. Hui, L. Li, A. Thambyah, J. Goh, E.H. Lee.
Enhancement of tendon graft osteointegration using mesenchymal stem cells in a rabbit model of anterior cruciate ligament reconstruction.
Arthroscopy, 20 (2004), pp. 899-910
[17]
H.W. Ouyang, J.C. Goh, E.H. Lee.
Use of bone marrow stromal cells for tendon graft-to-bone healing: histological and inmunohistochemical studies in a rabbit model.
Am J Sports Med, 32 (2004), pp. 321-327
[18]
L.V. Gulotta, D. Kovacevic, S. Montgomery, J.R. Ehteshami, J.D. Packer, S.A. Rodeo.
Stem cells genetically modified with the developmental gene MT1-MMP improve regeneration of the supraspinatus tendon-to-bone insertion site.
Am J Sports Med, 38 (2010), pp. 1429-1437
[19]
L.V. Gulotta, D. Kovacevic, J.D. Packer, X.H. Deng, S.A. Rodeo.
Bone marrow-derived mesenchymal stem cells transduced with scleraxis improve rotator cuff healing in a rat model.
Am J Sports Med, 39 (2011), pp. 1282-1289
[20]
F. Guilak, B.T. Estes, B.O. Diekman, F.T. Moutos, J.M. Gimble.
Nicolas Andry Award: multipotent adult stem cells from adipose tissue for musculoskeletal tissue engineering.
Clin Orthop Relat Res, 2010 (2010), pp. 2530-2540
[21]
D. Garcia-Olmo, D. Herreros, I. Pascual, J.A. Pascual, E. del-Valle, J. Zorrilla, et al.
Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.
Dis Colon Rectum, 52 (2009), pp. 79-86
[22]
P.D. Alvarez, M. Garcia-Arranz, T. Georgiev-Hristov, D. Garcia-Olmo.
A new bronchoscopic treatment of tracheomediastinal fistula using autologous adipose-derived stem cells.
Thorax, 63 (2008), pp. 374-376
[23]
J.B. Mitchell, K. McIntosh, S. Zvonic, S. Garrett, Z.E. Floyd, A. Kloster, et al.
Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers.
Stem Cells, 24 (2006), pp. 376-385
[24]
E. Gonzalez-Rey, M.A. Gonzalez, N. Varela, F. O’Valle, P. Hernandez-Cortes, L. Rico, et al.
Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis.
Ann Rheum Dis, 69 (2010), pp. 241-248
[25]
G. Arce, K. Bak, G. Bain, E. Calvo, B. Ejnisman, V.G. di Giacomo, et al.
Management of disorders of the rotator cuff: proceedings of the ISAKOS upper extremity committee consensus meeting.
Arthroscopy, 29 (2013), pp. 1840-1850

Please cite this article as: Barco R, Encinas C, Valencia M, Carrascal MT, García-Arranz M, Antuña S. Uso de células troncales derivadas de lipoaspirado en un modelo experimental animal de rotura de manguito rotador. Rev Esp Cir Ortop Traumatol. 2015;59:3–8.

Copyright © 2014. SECOT
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos